Kiniksa Pharmaceuticals
KNSA
KNSA
134 hedge funds and large institutions have $606M invested in Kiniksa Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 49 increasing their positions, 43 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more call options, than puts
Call options by funds: $5.21M | Put options by funds: $4.6M
8.04% more ownership
Funds ownership: 90.92% → 98.97% (+8%)
6% more funds holding
Funds holding: 127 → 134 (+7)
Holders
134
Holding in Top 10
2
Calls
$5.21M
Puts
$4.6M
Top Buyers
| 1 | +$30.7M | |
| 2 | +$8.75M | |
| 3 | +$8.59M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$7.82M |
| 5 |
Millennium Management
New York
|
+$4.74M |
Top Sellers
| 1 | -$6.56M | |
| 2 | -$6.29M | |
| 3 | -$5.31M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$5.22M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$4.08M |